M. Thomas Stillman

441 total citations
10 papers, 338 citations indexed

About

M. Thomas Stillman is a scholar working on Pharmacology, Rheumatology and Nephrology. According to data from OpenAlex, M. Thomas Stillman has authored 10 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 3 papers in Rheumatology and 2 papers in Nephrology. Recurrent topics in M. Thomas Stillman's work include Inflammatory mediators and NSAID effects (6 papers), Drug-Induced Adverse Reactions (2 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). M. Thomas Stillman is often cited by papers focused on Inflammatory mediators and NSAID effects (6 papers), Drug-Induced Adverse Reactions (2 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). M. Thomas Stillman collaborates with scholars based in United States. M. Thomas Stillman's co-authors include Joseph L. Blackshear, Jerold Napier, John T. Crosson, Morris Davidman, Martin Stillman, Peter A. Schlesinger and LoAnn Peterson and has published in prestigious journals such as The American Journal of Cardiology, Journal of the American Academy of Dermatology and Seminars in Arthritis and Rheumatism.

In The Last Decade

M. Thomas Stillman

10 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Thomas Stillman United States	8	139	69	66	46	41	10	338
Robert J. Holt United States	11	91 0.7×	112 1.6×	18 0.3×	19 0.4×	26 0.6×	46	358
R R Ghose United Kingdom	9	26 0.2×	15 0.2×	130 2.0×	18 0.4×	70 1.7×	34	366
Jean-Paul Dutertre France	8	74 0.5×	28 0.4×	6 0.1×	29 0.6×	8 0.2×	15	309
José Antonio Robles-Cervantes Mexico	14	88 0.6×	28 0.4×	21 0.3×	31 0.7×	11 0.3×	33	511
S H Roth United States	5	421 3.0×	111 1.6×	81 1.2×	49 1.1×	6 0.1×	6	692
Morris Davidman United States	9	64 0.5×	32 0.5×	45 0.7×	20 0.4×	165 4.0×	13	369
I. Scaricabarozzi Italy	13	178 1.3×	38 0.6×	17 0.3×	72 1.6×	2 0.0×	48	423
Lee Nelson United States	8	51 0.4×	7 0.1×	20 0.3×	28 0.6×	31 0.8×	11	464
Krister Delin Sweden	11	34 0.2×	22 0.3×	79 1.2×	18 0.4×	26 0.6×	31	411
Irl B. Hirsch United States	7	74 0.5×	16 0.2×	69 1.0×	17 0.4×	44 1.1×	14	919

Countries citing papers authored by M. Thomas Stillman

Since Specialization

Citations

This map shows the geographic impact of M. Thomas Stillman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Thomas Stillman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Thomas Stillman more than expected).

Fields of papers citing papers by M. Thomas Stillman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Thomas Stillman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Thomas Stillman. The network helps show where M. Thomas Stillman may publish in the future.

Co-authorship network of co-authors of M. Thomas Stillman

This figure shows the co-authorship network connecting the top 25 collaborators of M. Thomas Stillman. A scholar is included among the top collaborators of M. Thomas Stillman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Thomas Stillman. M. Thomas Stillman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Stillman, Martin & M. Thomas Stillman. (2007). Appropriate use of NSAIDs: considering cardiovascular risk in the elderly.. PubMed. 62(3). 16–21. 5 indexed citations

2.

Stillman, Martin & M. Thomas Stillman. (2007). Choosing nonselective NSAIDs and selective COX-2 inhibitors in the elderly. A clinical use pathway.. PubMed. 62(2). 26–34. 24 indexed citations

3.

Crosson, John T. & M. Thomas Stillman. (1997). Minocycline-related lupus erythematosus with associated liver disease. Journal of the American Academy of Dermatology. 36(5). 867–868. 41 indexed citations

4.

Stillman, M. Thomas. (1990). Nonsteroidal Anti-inflammatory Drug Nephrotoxicity. Archives of Internal Medicine. 150(2). 268–268. 70 indexed citations

5.

Stillman, M. Thomas. (1989). Interaction and Selection of Therapeutic Agents in The Elderly: NSAIDs and The Ageing Kidney. Scandinavian Journal of Rheumatology. 18(sup82). 33–38. 9 indexed citations

6.

Blackshear, Joseph L., Jerold Napier, Morris Davidman, & M. Thomas Stillman. (1985). Renal complications of nonsteroidal antiinflammatory drugs: Identification and monitoring of those at risk. Seminars in Arthritis and Rheumatism. 14(3). 163–175. 79 indexed citations

7.

Stillman, M. Thomas, Jerold Napier, & Joseph L. Blackshear. (1984). Adverse Effects of Nonsteroidal Anti-Inflammatory Drugs on the Kidney. Medical Clinics of North America. 68(2). 371–385. 48 indexed citations

8.

Schlesinger, Peter A., M. Thomas Stillman, & LoAnn Peterson. (1982). Polyarthritis with birefringent lipid within synovial fluid macrophages: case report and ultrastructural study. Arthritis & Rheumatism. 25(11). 1365–1368. 19 indexed citations

9.

Stillman, M. Thomas, et al.. (1969). Perforation of the interventricular septum by transvenous pacemaker catheter. The American Journal of Cardiology. 24(2). 269–273. 42 indexed citations

10.

Stillman, M. Thomas. (1967). Ethacrynic acid, a potent diuretic.. PubMed. 50(4). 573–85. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact